Exercise Testing in the Risk Assessment of Pulmonary Hypertension
CHEST · 2023-09 · 164 (3) · 736-746
DOI: 10.1016/j.chest.2023.04.013 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CHEST, 2023-09. Verfasst von Lindsay M Forbes und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Ventricular Dysfunction, Right. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
TOPIC IMPORTANCE: Right ventricular dysfunction in pulmonary hypertension (PH) contributes to reduced exercise capacity, morbidity, and mortality. Exercise can unmask right ventricular dysfunction not apparent at rest, with negative implications for prognosis. REVIEW FINDINGS: Among patients with pulmonary vascular disease, right ventricular afterload may increase during exercise out of proportion to increases observed among healthy individuals. Right ventricular contractility must increase to match the demands of increased afterload to maintain ventricular-arterial coupling (the relationship between contractility and afterload) and ultimately cardiac output. Impaired right ventricular contractile reserve leads to ventricular-arterial uncoupling, preventing cardiac output from increasing during exercise and limiting exercise capacity. Abnormal pulmonary vascular response to exercise can signify early pulmonary vascular disease and is associated with increased mortality. Impaired right ventricular contractile reserve similarly predicts poor outcomes, including reduced exercise capacity and death. Exercise provocation can be used to assess pulmonary vascular response to exercise and right ventricular contractile reserve. Noninvasive techniques (including cardiopulmonary exercise testing, transthoracic echocardiography, and cardiac MRI) as well as invasive techniques (including right heart catheterization and pressure-volume analysis) may be applied selectively to the screening, diagnosis, and risk stratification of patients with suspected or established PH. Further research is required to determine the role of exercise stress testing in the management of pulmonary vascular disease. SUMMARY: This review describes the current understanding of clinical applications of exercise testing in the risk assessment of patients with suspected or established PH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
- Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado; Rocky Mountain Regional VA Medical Center, Aurora, Colorado; Departmen…
- Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado; Department of Medicine, Division of Pulmonary, Critical Care and Sleep…
- Department of Medicine, Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado. Electronic address: william.cornwell@cuanschutz.edu.
Förderung
- NHLBI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Forbes, L. M., Bull, T. M., Lahm, T., Make, B. J., & Cornwell, W. K. (2023). Exercise Testing in the Risk Assessment of Pulmonary Hypertension. CHEST, 164(3), 736-746. https://doi.org/10.1016/j.chest.2023.04.013
Vancouver
Forbes LM, Bull TM, Lahm T, Make BJ, Cornwell WK. Exercise Testing in the Risk Assessment of Pulmonary Hypertension. CHEST. 2023;164(3):736-746. doi:10.1016/j.chest.2023.04.013
BibTeX
@article{Forbes2023,
author = {Forbes, Lindsay M and Bull, Todd M and Lahm, Tim and Make, Barry J and Cornwell, William K},
title = {Exercise Testing in the Risk Assessment of Pulmonary Hypertension},
journal = {CHEST},
year = {2023},
volume = {164},
number = {3},
pages = {736--746},
doi = {10.1016/j.chest.2023.04.013}
}
EUVIMED